Filing
Spy
Filing
Spy
Home
About
RPRX
Royalty Pharma Plc
Biopharmaceutical royalty company
CUSIP: G7709Q104
Healthcare
US
3 holders
Ownership
Activity
2023 Q4
9 of 23 quarters
Total Value
$319.20M
Total Shares
11.36M
Net Share Change
+1.71M
Activity
2 buying
1 selling
Investor
Value
Shares
Weight
Change
Viking Global Investors
$283.36M
10.09M
1.0%
ADD
+623.2K
(+6.6%)
Viking Global Investors
$283.36M
10.09M shares
ADD
+623.2K
(+6.6%)
Patient Capital Management
$35.25M
1.25M
1.9%
NEW
Patient Capital Management
$35.25M
1.25M shares
NEW
Bridgewater Associates LP
$594.0K
21.1K
0.0%
TRIM
-172.0K
(-89.1%)
Bridgewater Associates LP
$594.0K
21.1K shares
TRIM
-172.0K
(-89.1%)
RPRX — Royalty Pharma Plc - FilingSpy